Stock Information
Zenas Biopharma Inc (ZBIO)
Ticker Symbol: ZBIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,075.83 mil
Piotroski score: 5
PE Ratio: N/A
EPS (TTM): -8.97
Revenue (TTM): $0.02 M
Dividend Yield: N/A
ROE: -189.68%
Latest News
-
Can Zenas BioPharma’s (ZBIO) Clinical Pipeline Justify Its Heavy Cash Burn?
Wed, Sep 23, 2026 11:14 AM
-
Why Is Zenas BioPharma (ZBIO) Filing More Than $240 Million In Shelves?
Wed, Sep 23, 2026 4:32 AM
-
Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026
Tue, Sep 22, 2026 11:05 AM
-
Zenas BioPharma To Present New Data From Phase 3 INDIGO Trial Evaluating Obexelimab In IgG4-RD At 6th International Symposium On IgG4-Related Disease, And ACR Convergence 2026
Tue, Sep 22, 2026 7:15 AM
-
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fri, Sep 18, 2026 8:15 PM
Key Financials
Financial data not available
